A special app is used to evaluate the impact of the disease on the everyday life of patients and their families.
Greifswald/Bonn (Germany), July 11 2022. The DZNE is leading an international research…
DZNE researchers report in the journal "Cell".
New Study in the Journal “Cell”
Berlin (Germany)/Dallas (USA), July 8, 2022. Using a state-of-the-art method, researchers at DZNE and the University of…
The vaccine is targeting the most common genetic ALS variant.
The vaccine is targeting the most common genetic ALS variant
Bilthoven, the Netherlands / Munich, Germany, July 6, 2022. DZNE and …
Rhineland Study: The Extent of Abnormalities in the Brain’s White Matter Grows Significantly After Menopause.
The Extent of Abnormalities in the Brain’s White Matter Grows Significantly After…
The enemy in your own body
The immune system is supposed to protect against diseases. Sometimes, however, it becomes the aggressor itself: misdirected antibodies then attack the brain and…
Researchers from DZNE have identified a protein in the blood that may indicate the degradation of neural connections years before the onset of dementia symptoms.
Study of individuals with Down…
eDEM-CONNECT
Subproject DZNE site Witten
The task of the DZNE Witten is to provide the domain knowledge to promote stability. For this purpose, a literature research and analysis of selected…
Alzheimer doctoral scholarships by Hans and Ilse Breuer Foundation
Young researchers, take your chance and apply: The Hans and Ilse Breuer Foundation announces doctoral scholarships for 2023.…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
